Nneile Nkholise Is Building Medical Technology Around African Patients.
Nneile Nkholise is rethinking how medical technology can serve African patients.
For a patient waiting for a prosthetic limb or a specialised medical device, time matters. So does fit.
A device that does not adequately reflect a patient’s anatomy can affect comfort, usability and quality of life. Yet across many African healthcare systems, patients and clinicians have historically had to work with medical technologies developed and manufactured far from the communities they serve.
For Nneile Nkholise, that gap represented an opportunity for engineering to become more responsive to patients.
As the Founder of iMed Tech, Nkholise is developing locally manufactured prosthetics, bio-implants and other medical technologies using biomedical engineering, digital design and advanced manufacturing.
Her work sits at the intersection of healthcare and technology—but its starting point is human: how can medical devices be designed to better respond to the people who use them?
Nneile Nkholise is bringing engineering closer to healthcare
Medical innovation is often associated with large research institutions and global manufacturers.
But healthcare challenges are also shaped by local realities.
Availability, cost, production timelines and the ability to customise a device can all influence a patient’s experience. When specialised products have to be sourced internationally, healthcare providers may also face additional logistical and procurement challenges.
With her engineering background, Nneile Nkholise saw an opportunity to approach these challenges differently.
Instead of relying exclusively on technologies developed elsewhere, she founded iMed Tech to develop medical products closer to the healthcare professionals and patients who need them.
The company’s work combines biomedical engineering with digital manufacturing, creating a process in which clinical requirements can be translated into digitally designed and locally produced medical solutions.
What does iMed Tech do?
Its work includes the design and production of:
- Customised prosthetic devices
- Bio-implants and medical devices
- Three-dimensional anatomical models
- Surgical planning and visualisation tools
- Biomedical engineering solutions
- Rapid prototypes for healthcare applications
A key part of the company’s approach is the use of 3D design and digital modelling.
These technologies allow engineers to create and refine digital representations before producing a physical device. For medical applications, that can be particularly useful where anatomy, dimensions and individual patient requirements need to be considered.
The process also creates opportunities for faster iteration: a design can be modified digitally before another physical prototype is manufactured.
For iMed Tech, advanced manufacturing is therefore not simply about producing objects differently. It is about creating a more flexible approach to medical device development.
From digital model to medical solution
The journey from a clinical problem to a finished medical device involves several disciplines.
Doctors and surgeons understand the clinical requirement. Engineers translate that requirement into a technical design. Digital manufacturing technologies then make it possible to produce increasingly customised physical solutions.
Nneile Nkholise operates within that intersection.
Through iMed Tech, she is helping connect clinical knowledge, engineering and manufacturing within a single innovation ecosystem.
Three-dimensional anatomical models, for example, can help clinicians visualise complex structures before procedures. Custom prosthetics can be developed around individual measurements rather than relying entirely on standardised dimensions.
This convergence of medicine and engineering is creating new possibilities for African healthcare systems—particularly as digital manufacturing becomes more accessible.
The Tony Elumelu Foundation strengthened Nneile Nkholise’s entrepreneurial journey
Technical expertise is only one part of building a medical technology company.
Turning engineering capabilities into a sustainable enterprise requires commercial strategy, capital, mentorship and access to networks.
Through the Tony Elumelu Foundation Entrepreneurship Programme, Nneile Nkholise received US$5,000 in seed capital, business training, mentorship and access to the Foundation’s pan-African entrepreneurial network.
The support gave iMed Tech additional resources to strengthen its innovation and business development efforts.
For Nkholise, the experience brought together two sides of her professional journey: her expertise as an engineer and her ambition as an entrepreneur.
That combination is particularly important in medical technology, where successful innovation must ultimately work within real healthcare environments while also developing a viable commercial model.
Nneile Nkholise is also changing who gets to build medical technology
The significance of iMed Tech extends beyond the products it develops.
Biomedical engineering, advanced manufacturing and technology remain fields where women are often underrepresented.
Through iMed Tech, Nkholise is creating opportunities for young professionals to participate in areas including biomedical engineering, digital prototyping, additive manufacturing, research and development and clinical collaboration.
That matters because Africa’s healthcare technology ecosystem will require more than imported equipment.
It will require engineers, designers, scientists, technicians and entrepreneurs capable of developing technologies that respond to local needs.
Nneile’s journey provides an example of what that ecosystem can look like.
Why Nneile Nkholise’s work matters
Healthcare innovation is ultimately about access to effective solutions.
Hospitals need appropriate equipment. Clinicians need tools that support their work. Patients need medical devices that are available, functional and suited to their circumstances.
Local medical technology companies can contribute to that ecosystem by developing products closer to the markets they serve.
For Nneile Nkholise, this is the opportunity behind iMed Tech.
The company’s work demonstrates how African engineers can participate in the development of sophisticated medical technologies rather than remaining solely consumers of products manufactured elsewhere.
It also illustrates the potential of digital manufacturing to change how medical devices are designed and produced.
When a patient’s needs can inform a digital design, and that design can then be translated into a physical product locally, the distance between clinical need and engineering response becomes smaller.
Building Africa’s biomedical manufacturing capacity
There is a broader industrial question behind Nkholise’s work.
Africa’s healthcare systems depend on complex global supply chains for medicines, equipment and medical devices. Building stronger local capabilities does not mean eliminating international trade or expertise.
It means developing more capacity within African economies to design, manufacture, maintain and improve the technologies their healthcare systems use.
That is the space iMed Tech occupies.
By combining engineering expertise with entrepreneurship, Nneile Nkholise is contributing to a growing ecosystem of African companies exploring what is possible in medical manufacturing.
The opportunity is significant: local expertise can generate new products, new technical skills and new businesses while creating pathways for African innovators to participate in global health technology markets.
Medical technology is becoming increasingly personalised.
Advances in digital modelling, 3D printing, biomedical engineering and data-driven design are creating new possibilities for devices tailored to individual patients.
Nneile Nkholise believes Africa should be part of that future not simply as a consumer, but as a creator.
Through iMed Tech, she is building a business around that belief—developing medical technologies that connect engineering expertise with real healthcare needs.
The journey will require continued investment in research, manufacturing capabilities, clinical partnerships and regulatory systems.
But the direction is significant.
The future of African healthcare will depend not only on who can provide treatment, but also on who can build the technologies that make better treatment possible.
For Nneile Nkholise, that future is one where innovation begins closer to the patient.
And where Africa’s medical technology is increasingly designed, engineered and built on the continent.